CHINA BIOLOGIC PRODS INC's ticker is CBPOXXXX and the CUSIP is 16938C106. A total of 6 filers reported holding CHINA BIOLOGIC PRODS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $11,000 | +10.0% | 100 | 0.0% | 0.00% | – |
| Q1 2017 | $10,000 | -98.7% | 100 | -98.6% | 0.00% | -100.0% |
| Q4 2016 | $760,000 | -29.8% | 7,077 | -18.7% | 0.00% | 0.0% |
| Q3 2016 | $1,082,000 | +30.5% | 8,700 | +11.5% | 0.00% | 0.0% |
| Q2 2016 | $829,000 | +0.6% | 7,800 | +8.3% | 0.00% | 0.0% |
| Q1 2016 | $824,000 | -82.9% | 7,200 | -86.6% | 0.00% | -83.3% |
| Q3 2015 | $4,832,000 | – | 53,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPQ Asia Capital Ltd | 287,277 | $35,760,000 | 28.32% |
| WARBURG PINCUS LLC | 6,674 | $830,780,000 | 13.45% |
| Ariose Capital Management Ltd | 238,841 | $27,689,000 | 7.56% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 12,600 | $1,568,000 | 4.48% |
| RUDMAN ERROL M | 37,001 | $4,606,000 | 3.72% |
| INDUS CAPITAL PARTNERS, LLC | 245,237 | $30,527,000 | 2.89% |
| Ativo Capital Management LLC | 93,784 | $11,674,000 | 2.70% |
| OBERWEIS ASSET MANAGEMENT INC/ | 63,305 | $7,880,000 | 2.27% |
| Point72 Hong Kong Ltd | 31,500 | $3,921,000 | 2.14% |
| Cormorant Asset Management, LP | 112,867 | $14,050,000 | 1.55% |